The North America and Europe intravenous infusion pumps market size was valued at USD 4.45 billion in 2024 and is projected to grow at a CAGR of 8.10% from 2025 to 2030. This growth is attributed to the increase in the prevalence of chronic diseases such as respiratory diseases, stroke, diabetes, cancer, and cardiovascular diseases, wherein cardiovascular disease is the major cause of death in Europe and North America. For instance, according to the U.S. Department of Health and Human Services, an estimated 129 million people in the US have at least one major chronic disease. Intravenous infusion pumps ensure controlled, regulated, error-free delivery of nutrients and medications while treating patients via radiation therapy or chemotherapy, as these are very complex processes and require precise dosages of medication. The use of these pumps helps in reducing errors during administration, as medication errors are the most common types of errors and cannot be taken carelessly while handling patients with chronic diseases.

There is a need for advanced delivery systems that are safer, more efficient, and standardized. The introduction of smart infusion pumps or next-generation intravenous pumps is imparting greater growth opportunities for the overall pump market. Smart pumps are infusion devices that are embedded with a computer software system aimed at decreasing drug dosing errors through the presence of drug libraries, ensuring safe medication administration. For instance, in April 2024, Mackenzie Health in Canada became the first healthcare system to implement BD Alaris EMR Interoperability, enabling two-way communication between IV infusion pumps and electronic medical records (EMRs). This advancement eliminates the need for manual programming, significantly reducing medication administration errors while improving workflow efficiency. Studies show an 86% reduction in keystrokes needed for infusion programming. Such smart infusion technologies are driving market growth by increasing hospital demand for interoperable and automated IV pumps.

Market Concentration Characteristics

The market is witnessing a high degree of innovation through advanced technologies in software and programming. Smart infusion pumps are being increasingly adopted in both North America and Europe. Companies are focusing on research, development and seeking regulatory approvals for new infusion devices.

Several market players, such as ICU Medical, Inc., are involved in collaborations and partnerships with other leading players. Through strategic activities, these companies foster innovation, distribution, and geographical expansion to enhance their presence and address the growing demand for infusion pumps.

Regulations in the market have a significant impact, ensuring product safety and efficacy through stringent approvals. Regulatory compliance boosts consumer confidence and market acceptance. However, the lengthy approval processes can delay market entry and increase development costs for manufacturers.

Alternative product choices such as subcutaneous intrathecal and enteral pumps are gaining traction. These pumps are integrated with advanced technology, with connectivity to smartphones.

Get a preview of the latest developments in the North America And Europe Intravenous Infusion Pumps Market? Download your FREE sample PDF copy today and explore key data and trends

North America And Europe Intravenous Infusion Pumps Market Report Segmentation

Grand View Research has segmented the North America and Europe intravenous infusion pumps market report on the basis of product, disease indication, end-use, and region:

• Product Outlook (Revenue, USD Million, 2018 - 2030)
  • Volumetric Infusion Pumps
  • Syringe Infusion Pumps
  • Ambulatory Infusion Pumps
  • Patient-Controlled Analgesia Infusion Pumps
  • Implantable Infusion Pumps
  • Others
• Disease Indication Outlook (Revenue, USD Million, 2018 - 2030)
  • Chemotherapy
  • Diabetes
  • Gastroenterology
  • Analgesia/Pain Management
  • Pediatrics/Neonatology
  • Hematology
  • Others
• End-use Outlook (Revenue, USD Million, 2018 - 2030)
  • Hospitals
  • Homecare
  • Others
• Regional Outlook (Revenue, USD Million, 2018 - 2030)
  • North America
    • US
    • Canada
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Denmark
    • Sweden
    • Norway

Key North America And Europe Intravenous Infusion Pumps Companies:

• Baxter
• B. Braun Melsungen AG
• Fresenius Kabi AG
• ICU Medical, Inc. (Smiths Medical)
• Micrel Medical Devices SA
• Boston Scientific Corporation
• BD
• Terumo Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
• Moog Inc.
• IRadimed Corporation
• CODAN Companies
• Arcomed

Recent Developments

• In November 2024, ICU Medical, Inc. and Otsuka Pharmaceutical Factory, Inc. announced a joint venture to enhance supply chain resiliency and innovation in the North American IV solutions market. Combining Otsuka’s extensive global manufacturing capabilities with ICU Medical’s strong North American production and distribution, the partnership aims to deliver advanced IV pumps and consumables to healthcare providers. The agreement includes a USD 200 million upfront payment from OPF to ICU Medical, with additional performance-based milestones and long-term collaboration plans.
• In January 2024, Lemer Pax, a global leader in radiation protection, signed a partnership with ICU Medical, a leader in infusion systems, to distribute the Plum 360 pump in the French nuclear medicine sector to expand its sales in the European market.

Order a free sample PDF of the North America And Europe Intravenous Infusion Pumps Market Intelligence Study, published by Grand View Research.